On Monday, shares of Boston Scientific Corp. (BSX) saw an RSI (Relative Strength Index) reading of 28.3, indicating that they are in oversold territory. This occurred as the stock traded as low as $36.295 per share, significantly below the S&P 500 ETF’s RSI of 33.9. Investors may interpret this as a potential buying opportunity, suggesting that heavy selling may be nearing its end.
Boston Scientific’s stock price has a 52-week range with a low of $36.295 and a high of $47.495, closing at $36.59. This data highlights the recent volatility in the stock’s performance and may attract bullish investors looking for entry points.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
